Biomedical Innovation in Emergency Bleeding Treatment

In emergencies, time is often the difference between life and death. Severe bleeding is a major contributor to 
preventable deaths, with approximately 1.75 million lives lost each year worldwide [1]. Cresilon has developed 
Traumagel to help address this problem. Traumagel is a hemostatic gel capable of controlling bleeding within 
seconds. The product is intended to be simple and intuitive to use, allowing it to integrate seamlessly into emergency 
care situations. Additionally, it reduces the need to pack a wound, improving safety for emergency responders by 
limiting exposure to a patient’s blood.

The application process is straightforward. After clearing excess blood from the wound, the gel is injected directly 
into the bleeding source using a syringe. Gauze is then applied on top of the gel, and moderate pressure is maintained 
for approximately three minutes to allow the gel to form a temporary barrier that controls bleeding.
In a case report involving a head laceration, Traumagel was successfully used to control hemorrhage that was 
unresponsive to direct pressure and traditional methods [2]. The intervention had no reported complications, and the 
authors emphasized the importance of adopting new technologies such as Traumagel to improve patient outcomes.
The product was granted a 510(k) clearance and is now available for widespread use for EMTs, paramedics, first 
responders, and trauma healthcare providers. 

Traumagel is a plant-based viscous gel intended for single use. When applied to a wound, the gel adheres to the 
tissue and rapidly forms a barrier that stops blood flow while supporting the body’s natural clotting process. 
However, it must later be removed by medical personnel, as it serves only as a temporary hemostatic solution. Many 
currently available products are time-consuming to prepare, can be difficult to use, and may not function effectively 
for severe hemorrhages.
While the need for such interventions is hopefully rare, technologies like Traumagel demonstrate how biomedical 
innovation can play a critical role in improving survival during medical emergencies.

Written by 

References
[1] “Trauma care,” Cresilon, https://cresilon.com/traumagel/ (accessed Mar. 12, 2026). 
[2] D. Kleiman, T. Carruth, J. Infanzon, M. Nix, and B. Goldstone, “The use of TRAUMAGEL® for hemorrhage 
control in a complex head laceration: A case report,” Open Access Emergency Medicine, vol. Volume 17, pp. 339–
343, Nov. 2025. doi:10.2147/oaem.s546914

Back To Medical Marketing